Lirio was recently featured in MM+M as one of five AI-powered pharma marketing tools that clients say truly deliver results. The article highlights how Lirio’s Precision Nudging® technology combines behavioral science and AI to personalize outreach at the individual level—helping health systems and life sciences organizations drive measurable improvements in adherence, engagement, and outcomes at scale.
Amy Bucher, PhD. Chief Behavioral Officer of Lirio (Knoxville, Tenn.). Dr. Bucher, an internationally recognized expert in motivation science and behavioral product design, leads Lirio’s behavioral science team, where she develops AI-powered Precision Nudging solutions that enhance health outcomes through behavior design. She co-directs Lirio’s behavioral reinforcement learning lab and supports a $7.3 million Advanced Research Projects Agency for Health initiative with Vanderbilt to improve healthcare chatbot reliability. She also authored Engaged: Designing for Behavior Change, and holds two patents in digital health personalization. Dr. Bucher has transformed behavioral science into machine-readable content for AI systems, helping Lirio blend research, empathy and cutting-edge tech to empower patients at scale. Her influence extends past the company to include keynote speeches, academic leadership and pioneering real-world pplications of behavioral AI in healthcare.